Sunshine Biopharma Inc. Income Statement
SBFM|14 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 14 fiscal years. All figures from audited SEC 10-K filings.
Sunshine Biopharma Inc. reported $35M in revenue and $5M in net loss for FY2025. Revenue has grown at a 201.2% compound annual rate over the past 9 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $34.9M | $24.1M | $4.3M | $228.4K | $71.4K | $21.1K | $0 | $0 | $0 | $1.7K | $0 | $0 | $0 | $0 |
| Cost of Revenue | $24.2M | $15.8M | $2.6M | $117.8K | $25.8K | $11.1K | $0 | $0 | - | - | - | - | - | - |
| Gross Profit | $10.7M | $8.3M | $1.7M | $110.6K | $45.6K | $10.1K | $0 | $0 | - | - | - | - | - | - |
| SG&A Expense | $16.5M | $13.1M | $28.7M | $2.6M | $622.4K | $651.7K | $1.2M | $857.2K | $993.1K | $782.0K | $1.8M | $1.9M | $706.7K | $537.4K |
| R&D Expense | $933.9K | $1.9M | $811.9K | $672.2K | $1.7K | $15.2K | $12.8K | $0 | $32.8K | $8.7K | $327.0K | $137.4K | $1.8K | $0 |
| Operating Income | -$5.8M | -$4.8M | -$27.0M | -$2.4M | -$576.9K | -$641.6K | -$1.2M | -$857.2K | -$993.1K | -$780.3K | -$1.8M | -$1.9M | -$706.7K | - |
| Interest Expense | - | - | $39.4K | $328.8K | $168.1K | $115.9K | $143.5K | $104.8K | $34.7K | $307.2K | $140.9K | $6.5K | $1.3K | - |
| Income Tax | -$234.9K | $395.2K | $233.3K | $0 | $0 | - | - | - | - | - | - | - | - | - |
| Net Income | -$5.1M | -$4.5M | -$26.7M | -$12.4M | -$2.8M | -$1.7M | -$2.2M | -$1.0M | -$3.5M | -$1.7M | -$1.9M | -$2.5M | -$650.1K | -$650.1K |
| EPS (Basic) | -$7.32 | -$351.36 | -$1.76 | -$4.76 | -$2.73 | -$0.15 | -$0.71 | -$0.02 | -$0.01 | -$0.01 | -$0.03 | -$0.04 | -$0.01 | -$0.02 |
| EPS (Diluted) | - | -$351.36 | -$1.76 | -$4.76 | - | - | - | - | - | - | - | - | - | - |
| Shares Outstanding | 2.6M | 14.0K | 22.6M | 2.6M | 1.7M | 35.3M | 4.3M | 45.9M | 769.4M | 198.3M | 73.6M | 60.3M | 51.4M | 30.7M |
| Gross Margin | 30.6% | 34.6% | 39.0% | 48.4% | 63.8% | 47.7% | - | - | - | - | - | - | - | - |
| Operating Margin | -16.7% | -19.9% | -621.3% | -1068.2% | -807.8% | -3037.9% | - | - | - | -45683.7% | - | - | - | - |
| Profit Margin | -14.7% | -18.7% | -615.4% | -5444.4% | -3898.7% | -7860.9% | - | - | - | -96774.5% | - | - | - | - |